Literature DB >> 11860700

Vulvodynia--new and more effective approaches to therapy.

C M Bates1, D J Timmins.   

Abstract

Two cases are described of treatment-resistant vulvodynia that responded well to gabapentin. Gabapentin, an anti-epileptic drug, has been used in the treatment of neuropathic pain such as diabetic neuropathy and post-herpetic neuralgia. However, there has been little experience of its use in the relief of symptoms in vulvodynia and we add our observations to the one report of its use in these circumstances that has been published so far.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11860700     DOI: 10.1258/0956462021924802

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  3 in total

1.  Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia.

Authors:  Laurence Jerome
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

Review 2.  Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches.

Authors:  Natalie O Rosen; Samantha J Dawson; Melissa Brooks; Susan Kellogg-Spadt
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

3.  A streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentin.

Authors:  Gowhar Ali; Fazal Subhan; Muzaffar Abbas; Jehan Zeb; Muhammad Shahid; Robert D E Sewell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-07-03       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.